JP2009527498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527498A5 JP2009527498A5 JP2008555524A JP2008555524A JP2009527498A5 JP 2009527498 A5 JP2009527498 A5 JP 2009527498A5 JP 2008555524 A JP2008555524 A JP 2008555524A JP 2008555524 A JP2008555524 A JP 2008555524A JP 2009527498 A5 JP2009527498 A5 JP 2009527498A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- capcna
- amino acid
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74331306P | 2006-02-17 | 2006-02-17 | |
| PCT/US2007/062335 WO2007098415A2 (en) | 2006-02-17 | 2007-02-16 | Peptide based inhibition of capcna protein-protein interactions in cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009527498A JP2009527498A (ja) | 2009-07-30 |
| JP2009527498A5 true JP2009527498A5 (cg-RX-API-DMAC7.html) | 2009-10-22 |
Family
ID=38235155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555524A Pending JP2009527498A (ja) | 2006-02-17 | 2007-02-16 | 癌におけるcaPCNA相互作用のペプチドによる抑制 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8653039B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1989225A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009527498A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101384618A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007217037A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0707948A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2638866C (cg-RX-API-DMAC7.html) |
| EA (1) | EA200801847A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098415A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
| WO2008036929A2 (en) * | 2006-09-21 | 2008-03-27 | Alnylam Pharmaceuticals, Inc. | Complex for transferring an anionic substance into a cell |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| CA2732737C (en) * | 2008-07-24 | 2019-03-05 | Indiana University Research And Technology Corporation | Cancer peptide therapeutics |
| FR2942798B1 (fr) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | Peptides utilisables pour le traitement de la leucemie lymphoide chronique |
| WO2011044374A1 (en) * | 2009-10-07 | 2011-04-14 | Indiana University Research And Technology Corporation | Capcna peptide therapeutics for cancer |
| EP2538959A1 (en) * | 2010-02-24 | 2013-01-02 | Institut National de la Santé et de la Recherche Médicale | Compounds for the treatment of inflammation and neutropenia |
| JP2013522613A (ja) * | 2010-03-18 | 2013-06-13 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 化学療法に対する応答性を予測するための方法 |
| US9475840B2 (en) | 2012-02-27 | 2016-10-25 | Universitat De Barcelona | Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| US10420840B2 (en) * | 2015-04-10 | 2019-09-24 | Rll, Llc | Anticancer therapeutic agents |
| JP2020514256A (ja) * | 2016-12-15 | 2020-05-21 | ザ ナショナル インスティチュート フォー バイオテクノロジー イン ザ ネゲヴ,リミテッド | 抗pcnaモノクローナル抗体及びその使用 |
| GB201815041D0 (en) | 2018-09-14 | 2018-10-31 | Scancell Ltd | Epitopes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935797A (en) | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
| GB9509557D0 (en) * | 1995-05-11 | 1995-07-05 | Univ Dundee | PCNA binding substance |
| JP2002518341A (ja) * | 1998-06-15 | 2002-06-25 | アーチ・デヴェロップメント・コーポレイション | 放射線療法と抗血管形成因子の組み合わせ |
| US7294471B2 (en) | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| MX2007013584A (es) | 2005-04-27 | 2008-04-22 | Univ Indiana Res & Tech Corp | Anticuerpos de isoforma de cspcna y sus usos. |
| DE602006021178D1 (de) | 2005-06-27 | 2011-05-19 | Univ Indiana Res & Tech Corp | Cspcna-isoform-modifikationen und anwendungen davon |
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
-
2007
- 2007-02-16 EA EA200801847A patent/EA200801847A1/ru unknown
- 2007-02-16 CA CA2638866A patent/CA2638866C/en active Active
- 2007-02-16 AU AU2007217037A patent/AU2007217037A1/en not_active Abandoned
- 2007-02-16 CN CNA2007800052894A patent/CN101384618A/zh active Pending
- 2007-02-16 JP JP2008555524A patent/JP2009527498A/ja active Pending
- 2007-02-16 BR BRPI0707948-6A patent/BRPI0707948A2/pt not_active Application Discontinuation
- 2007-02-16 EP EP07757135A patent/EP1989225A2/en not_active Withdrawn
- 2007-02-16 WO PCT/US2007/062335 patent/WO2007098415A2/en not_active Ceased
- 2007-02-16 US US12/279,028 patent/US8653039B2/en active Active
-
2014
- 2014-02-18 US US14/182,550 patent/US9187526B2/en active Active
-
2015
- 2015-10-29 US US14/926,904 patent/US20160304559A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7007423B2 (ja) | 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物 | |
| JP2022078262A (ja) | 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物 | |
| ES2381206T3 (es) | Inhibidores peptídicos con permeabilidad celular de la ruta de transducción de la señal JNK | |
| CN101263157B (zh) | Jnk信号转导通路的细胞通透肽抑制剂 | |
| US9527895B2 (en) | CAPCNA peptide therapeutics for cancer | |
| US20160324976A1 (en) | Peptide having cell membrane penetrating activity | |
| US20080090770A1 (en) | Modulation of Muc1 Mediated Signal Transduction | |
| US20120142613A1 (en) | Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway | |
| EP2913057B1 (en) | Cancer peptide therapeutics | |
| CN104147591A (zh) | Jnk信号转导通路的细胞可渗透性肽抑制剂用于治疗各种疾病的应用 | |
| JP2009527498A (ja) | 癌におけるcaPCNA相互作用のペプチドによる抑制 | |
| US20130157260A1 (en) | Identification of compounds that regulate apoptosis | |
| US20190201483A1 (en) | ATF5 Peptide Variants and Uses Thereof | |
| US20080274956A1 (en) | Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein | |
| CN101300270A (zh) | 未活化的Wnt抑制多肽及其制备方法 | |
| US20130237476A1 (en) | Adipose tissue targeted peptides | |
| US9567369B2 (en) | Method of treating metastatic cancer | |
| JP2010254699A (ja) | Fas関連因子1(fasassociatedfactor1) | |
| CN113166216A (zh) | 源自人lrrc24蛋白的跨膜结构域 | |
| Guo et al. | Effects of the TAT peptide orientation and relative location on the protein transduction efficiency | |
| CN105555796A (zh) | 抑制肽对治疗炎性疾病的用途 | |
| WO2014178680A1 (ko) | Hsp 발현 억제 펩티드 및 이를 포함하는 조성물 | |
| WO2011079431A1 (zh) | 具有端粒酶抑制活性的融合蛋白、其制备方法和用途 | |
| JP2008505846A (ja) | 悪性哺乳動物細胞および形質転換哺乳動物細胞に対して選択的に致死性を有するペプチド | |
| CN101010337A (zh) | Fas相关因子1 |